Pell J P, McIver B, Stuart P, Malone D N, Alcock J
Milesmark Hospital, Rumblingwell, Fife.
Br J Gen Pract. 1993 Apr;43(369):152-4.
Management of patients receiving oral anticoagulant therapy was assessed in general practice and a dedicated hospital anticoagulant clinic. The demographic characteristics of patients in both groups were similar, as were the indications for anticoagulation therapy and the duration of treatment. General practice patients were reviewed significantly more frequently, with a median interval of 16 days compared with 42 days for hospital patients (P < 0.001). Twenty four per cent of general practice visits and 26% of hospital attendances resulted in an alteration to the warfarin dosage. Overall, 52% of general practice thrombotest results lay within the ranges recommended by the British Society for Haematology, compared with 45% of hospital results (P < 0.001). There was no difference in the rate of complications in general practice and the hospital clinic. In this study, the anticoagulant control achieved in a general practice setting was superior to that in a dedicated hospital outpatient clinic, although control was far from ideal in either setting.
在全科医疗和专门的医院抗凝门诊中,对接受口服抗凝治疗的患者的管理情况进行了评估。两组患者的人口统计学特征相似,抗凝治疗的指征和治疗持续时间也相似。全科医疗患者的复查频率明显更高,中位间隔时间为16天,而医院患者为42天(P<0.001)。24%的全科医疗就诊和26%的医院就诊导致华法林剂量改变。总体而言,52%的全科医疗凝血试验结果在英国血液学学会推荐的范围内,而医院的这一比例为45%(P<0.001)。全科医疗和医院门诊的并发症发生率没有差异。在本研究中,全科医疗环境下实现的抗凝控制优于专门的医院门诊,但在两种环境下控制都远非理想。